The peripheral iv catheters market has seen considerable growth due to a variety of factors.
• The market size of peripheral iv catheters has seen substantial growth in the past years. The market, currently valued at $5.43 billion in 2024, is projected to increase to $5.79 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%.
The historical growth is due to factors such as the expansion of healthcare facilities, an aging population, prevalence of chronic diseases, surgical and medical treaties, increased number of hospital admissions, and rising demand for vascular access devices.
The peripheral iv catheters market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for peripheral iv catheters is projected to experience robust growth in the coming years. The value of the market is estimated to rise to $8.36 billion in 2029, expanding at a compound annual growth rate (CAGR) of 9.6%.
The anticipated growth can be attributed to factors such as the increased use of minimally invasive procedures and catheters, the adoption of short peripheral catheters in outpatient care, prevention of catheter-related bloodstream infections, the growing expansion of home healthcare and the integration of antimicrobial coatings. Key trends for the forecast period incorporate the use of ultrasound guidance for peripheral iv catheter insertion, a reduction in complications and catheter failures, the implementation of wireless communication for monitoring catheters, an emphasis on patient-oriented catheter care, and a move towards disposable catheters.
The peripheral IV catheters market is predicted to expand due to the increasing occurrence of chronic illnesses. Peripheral IV catheters are predominantly employed to handle a range of chronic illnesses like cancer, cardiovascular disorders, among others. For example, data from the Australian Bureau of Statistics in March 2022 showed that about half the population (46.6% or 11.6 million people) reported having at least one chronic illness. The most frequently reported chronic ailments were mental and behavioral disorders (20.1%), back discomfort (15.7%), and arthritis (12.5%). Consequently, as the incidence of chronic diseases rises, it is anticipated to stimulate the expansion of the peripheral IV catheters market.
The peripheral iv catheters market covered in this report is segmented –
1) By Product Type: Short Peripheral Intravenous Catheters, Integrated/Closed Peripheral Intravenous Catheters (PIVC)
2) By Technology: Conventional Peripheral Intravenous Catheters (PIVC), Safety Peripheral Intravenous Catheters (PIVC)
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare
Subsegments:
1) By Short Peripheral Intravenous Catheters: Over-the-Needle Catheters, Winged Infusion Sets
2) By Integrated/Closed Peripheral Intravenous Catheters (PIVC): Safety Catheters, Antimicrobial Catheters, Smart Catheters
The peripheral IV catheters market is evolving due to technological advancements. Several companies are striving to offer their users technically superior products. B. Braun Medical, an American infusion therapy organization, brought out the new Introcan Safety 2 IV cathetar that offers a single-time blood control feature. This innovative product aids in making IV access safer for medical professionals by mitigating the dangers of needlestick injuries.
Major companies operating in the peripheral iv catheters market include:
• Becton
• Dickinson and Company
• B. Braun Melsungen AG
• Smiths Medical Inc.
• Vygon SAS
• Terumo Corporation
• Teleflex Incorporated
• NIPRO Medical Corporation
• Argon Medical Devices Inc.
• Medical Components Inc.
• Vascular Pathways Inc.
• Tangent Medical Technologies Inc.
• Vigmed AB
• Venner Medical
• C. R. Bard Inc.
• MedSource Labs
• Intra Special Catheters GmbH
• Greiner Bio-One International GmbH
• Ares Medikal
• Ace Medical Company
• Heka s.r.l
• Raumedic AG
• Vogt Medical Vertrieb GmbH
• RenovoRx Inc.
• Retractable Technologies Inc.
• AngioDynamics Inc.
• ICU Medical Inc.
• Medtronic plc
• Edwards Lifesciences Corporation
• Cook Group Incorporated
• Stryker Corporation
• Boston Scientific Corporation
• Johnson & Johnson
• Abbott Laboratories
• Merit Medical Systems Inc.
North America was the largest region in the peripheral IV catheters market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral iv catheters market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.